Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

RENEVAS - Red de Investigación Cooperativa Neurovascular

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Instituto de Salud Carlos III
Funding: 793573.69
Reference: RD06/0026/0010
Duration: 02/01/2007 - 31/12/2013

Geno-tPA: búsqueda de patrones genéticos predictivos de la evolución del paciente con ictus isquémico después del tratamiento con t-PA

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Anna Rosell Novel, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 25000
Reference: FMMA/04/2005
Duration: 23/06/2006 - 22/06/2009

Identificación de biomarcadores de isquemia cerebral mediante análisis de expresión génica y proteica de diferentes poblaciones celulares obtenidas por microscopia-catapultaje en core y penumbra tras el ictus en humanos

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Anna Rosell Novel
Funding agency: Instituto de Salud Carlos III
Funding: 221935
Reference: PI050322
Duration: 01/01/2006 - 31/05/2009

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Maria Jose Herrero Mata

Maria Jose Herrero Mata

Postdoctoral researcher
Transfusional Medicine
Read more
Cristina Aguilar Riera

Cristina Aguilar Riera

Growth and Development
Read more
Elena Muro Blanc

Elena Muro Blanc

Predoctoral researcher
Translational Molecular Pathology
Read more
Sara Albarral Perez

Sara Albarral Perez

Administrative
Purchase and Biddings Unit
Finance Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.